Boxer Capital, Llc Tyra Biosciences, Inc. (TYRA) insider trading activity

Boxer Capital, LLC is of Tyra Biosciences, Inc.. Currently has a direct ownership of 6.45 Million shares of TYRA, which is worth approximately $94.8 Million. The most recent transaction as insider was on Dec 17, 2021, when has been sold 125,000 shares (Common Stock) at a price of $13.12 per share, resulting in proceeds of $1,640,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.45M

0% 3M change

0% 12M change

Total Value Held $94.8 Million

Boxer Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 17 2021	BUY Open market or private purchase	$1,640,000 $13.12 p/Share	125,000 Added 1.9%	6,448,359 Common Stock
Sep 17 2021	BUY Open market or private purchase	$10,000,000 $16.0 p/Share	625,000 Added 8.99%	6,323,359 Common Stock
Sep 17 2021	BUY Conversion of derivative security	-	5,986,454 Added 95.41%	288,095 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

ODTC

Odonate Therapeutics, Inc. Financial Services

> 10% Shareholder

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

SLDB

Solid Biosciences Inc. Healthcare

> 10% Shareholder

PAND

Pandion Therapeutics, Inc.

> 10% Shareholder

ITOS

iTeos Therapeutics, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

RAIN

Rain Therapeutics Inc. Healthcare

TNGX

Tango Therapeutics, Inc. Healthcare

BCL